Last reviewed · How we verify
NCT02972918: OPL
Preoperative Optimization Levosimendan in Heart Failure Patients Undergoing Hip Fracture
trial testing Levosimendan in Ventricular Dysfunction, Left in 19 participants. Completed in 1 April 2019.
1 September 2018
Quick facts
| Lead sponsor | Hospital Universitario de Canarias |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 19 |
| Start date | 1 May 2014 |
| Primary completion | 1 September 2018 |
| Estimated completion | 1 April 2019 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Levosimendan (LEVOSIMENDAN) — full drug profile →
Conditions studied
- Ventricular Dysfunction, Left — all drugs for Ventricular Dysfunction, Left →
- Hip Fracture — all drugs for Hip Fracture →
Sponsor
Hospital Universitario de Canarias
Who can join
Adults 18 to 100, any sex, with Ventricular Dysfunction, Left or Hip Fracture. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
The effects of Levosimendan on left ventricular function.
Time frame: Baseline and every 24 hours postoperative, 48 h postoperative, and 7 days and after 30 days postoperative.
Changes of left ventricular function as assessed transthoracic. -
Change in cardiac index
Time frame: 48 hours after start of iv infusion
Measured through arterial pulse wave analysis. A baseline measurement is done before infusion is started
Sponsor's own description
The purpose of this study is to evaluate whether preoperative optimization with levosimendan in heart failure patients undergoing hip fracture surgery improves haemodynamic and tissue perfusion parameters.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02972918
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Levosimendan
Trials testing the same drug.
- NCT07262723 — Levosimendan in Acute Decompensated Heart Failure · Phase 2, PHASE3 · not yet recruiting
- NCT05664191 — Levosimendan as Treatment of Aneurysmal SubArachnoid Haemorrhage · Phase 2 · recruiting
- NCT06021587 — Interest of Levosimendan Preconditioning for Cardiac Surgery Under CEC in Heart Failure Patients With Impaired Ejection · unknown
- NCT05730907 — Efficacy and Clinical Outcomes of Levosimendan in E-CPR · unknown
- NCT05233202 — Levosimendan Versus Placebo Before Tricuspid Valve Surgery in Patients With Right Ventricular Dysfunction · Phase 3 · unknown
Other recruiting trials for Ventricular Dysfunction, Left
Currently open trials in the same condition.
- NCT06949748 — Flecainide in Idiopathic Premature Ventricular Contractions and Related Cardiomyopathy · recruiting
- NCT02931240 — BioVentrix Revivent TC™ System Clinical Study · NA · active not recruiting
Other Hospital Universitario de Canarias trials
Trials by the same sponsor.
- NCT05956119 — Effectiveness of Dry Needling for Improving Gait in the Patient With Multiple Sclerosis · NA · completed
- NCT05141773 — Artificial Intelligence Aid Systems and Endocuff in Colorectal Adenoma Detection · NA · completed
- NCT05553977 — Artificial Intelligence and Bowel Cleansing Quality · unknown
- NCT04945044 — Artificial Intelligence Aid Systems in Colorectal Adenoma Detection · NA · completed
- NCT05053984 — Ultrasound-Guided Percutaneous Neuromodulation in Spasticity · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02972918 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Universitario de Canarias
- Last refreshed: 3 February 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02972918.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing